Hydrogenetics, Inc. (HYGN)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 5, 2026
Hydrogenetics Statistics
Total Valuation
Hydrogenetics has a market cap or net worth of 36,326.
| Market Cap | 36,326 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Hydrogenetics has 363.26 million shares outstanding.
| Current Share Class | 363.26M |
| Shares Outstanding | 363.26M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +18.57% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.11 |
| P/TBV Ratio | 0.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.21, with a Debt / Equity ratio of 1.49.
| Current Ratio | 6.21 |
| Quick Ratio | 6.21 |
| Debt / Equity | 1.49 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.08 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -31.71% |
| Return on Invested Capital (ROIC) | -35.01% |
| Return on Capital Employed (ROCE) | -41.63% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -650,086 |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9,900.00% in the last 52 weeks. The beta is -4,648.78, so Hydrogenetics's price volatility has been lower than the market average.
| Beta (5Y) | -4,648.78 |
| 52-Week Price Change | +9,900.00% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 48.12 |
| Average Volume (20 Days) | 179,120 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 12.56 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -304,957 |
| Pretax Income | -650,086 |
| Net Income | -650,086 |
| EBITDA | -304,343 |
| EBIT | -304,957 |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 815,482 in cash and 488,617 in debt, with a net cash position of 326,865 or 0.00 per share.
| Cash & Cash Equivalents | 815,482 |
| Total Debt | 488,617 |
| Net Cash | 326,865 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 327,293 |
| Book Value Per Share | 0.00 |
| Working Capital | 684,191 |
Cash Flow
| Operating Cash Flow | -293,990 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Hydrogenetics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -442.20% |
| Shareholder Yield | -442.20% |
| Earnings Yield | -1,789.59% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 3, 2008. It was a reverse split with a ratio of 0.0001.
| Last Split Date | Oct 3, 2008 |
| Split Type | Reverse |
| Split Ratio | 0.0001 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |